Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
about
Case-control study of occupational exposure to electric shocks and magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991-1999A comprehensive review of amyotrophic lateral sclerosisBeing PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.Prognostic factors for the course of functional status of patients with ALS: a systematic review.Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort StudyAssociation between diabetes and amyotrophic lateral sclerosis in Sweden.Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosisComorbidities in Neurology: Is adenosine the common link?Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort studyAntecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.Angiotensin-converting enzyme inhibitors and motor neuron disease: An unconfirmed association.Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival.An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis.Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study.Cardiometabolic health and risk of amyotrophic lateral sclerosis.How Can a Ketogenic Diet Improve Motor Function?Depression in amyotrophic lateral sclerosis
P2860
Q23923926-71125315-0909-4FFD-8387-128AF5C1721CQ26775401-949FD69F-8A3D-4401-8BBE-0D0F143B0AB5Q28649394-6054572D-6776-4210-A57B-0A87E524CC1CQ30656923-0C6BF441-401A-45DA-9EC7-CB2522EA8933Q34447158-947C52C1-10B2-457E-BADB-A95F92D8C227Q35561543-5382DDF4-C59A-4BF9-8F18-18EB5C825E54Q35649275-560170CD-A7F9-4C4E-A2E7-1D6E5C21E299Q35864714-60BE7842-763D-4068-B336-52484D3E3C69Q35952241-70B6F212-887A-476F-B402-097F40632F38Q35956389-E2525510-1D43-4D50-BB7D-D7FBC78FB4BFQ36181514-D47E2DC7-3238-4F10-B3E3-C40666ABDD10Q36735465-F862D6BA-5100-4168-8352-E68F7B492D72Q37227101-A9E83397-E08C-4E36-8200-01A417B87328Q38811833-10A57105-C423-412D-B440-B181A7115F2AQ39076065-B3362771-3336-4723-B009-69CC787EDE93Q39970174-6B5B2F2F-5CDD-454E-A31C-26B2584F735EQ40125264-908944FE-563C-44EA-A465-5C54D06CC3F9Q41693587-A1109C15-7021-45F2-9C0C-349D0D36427EQ45388884-00421961-7785-4508-B153-F8C4075C20BEQ47801166-0CB72172-3E29-4E65-A0D0-BDD77349CA76Q48379805-EE934681-F246-4B3D-AC2A-B52FB60569C0Q49620553-010BDE20-BFC1-4C92-A593-6808F04C5049Q58486543-23A00318-EC66-45B9-930A-C01CAB677692
P2860
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@en
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@nl
type
label
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@en
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@nl
prefLabel
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@en
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@nl
P2093
P2860
P356
P1476
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
@en
P2093
A Müller-Heine
J Ilsemann
P2860
P304
P356
10.1111/ENE.12015
P577
2012-10-25T00:00:00Z